Large Clinical Trial Will Test Combination Monoclonal Antibody Therapy for Mild/Moderate COVID-19

Posted: 01/13/2021 | Leave a Comment

A Phase 2/3 clinical trial has begun to evaluate a combination investigational monoclonal antibody therapy for its safety and efficacy in people who have mild or moderate COVID-19. The two experimental antibodies, BRII-196 and BRII-198, target SARS-CoV-2, the virus that causes COVID-19. The trial, known as ACTIV-2, is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

https://www.nih.gov/news-events/news-releases/large-clinical-trial-will-test-combination-monoclonal-antibody-therapy-mild-moderate-covid-19

Dr. Tonya E. Thornton, Ph.D. – Critical Infrastructure Resilience and Disaster Recovery

Dr. Thornton has contributed many products to HDIAC as a member of the HDIAC SME network. Her most recent work are two podcasts discussing the resiliency in the nation’s 16 critical infrastructure sectors. She has also recorded podcasts discussing disaster response and recovery, and presented a webinar on the role of communication, coordination, and collaboration for critical infrastructure resilience.

Read SME's Research

Critical Infrastructure Protection

Critical Infrastructure Protection is one of the HDIAC’s eight technical focus areas. This SOAR reviews the current state of emerging technologies and methodologies relating to the protection of infrastructure and resources critical to national security. The report takes a look at the evolution of our critical infrastructure protective measures, the physical and cyber threats to our critical infrastructure, and the role government has in working with the owners of the largely privately-owned infrastructure assets. Read the SOAR

Alternative Energy: An Enabler of Military Capability

Alternative Energy is one of the HDIAC’s eight technical focus areas. This SOAR reviews the current state of a selection of novel, non-traditional, and/or emerging sources and technologies for harvesting, generating, and reusing energy. It offers synopses of new programs; summaries of significant technological breakthroughs and technology applications; highlights of outstanding developments; and impacts to the DoD. Read the SOAR

Operational Energy - Powering Military Operations to Achieve National Defense Strategy Objectives

Volume 7, Issue 1 of the HDIAC Journal contains article covering several of HDIAC's eight technical focus areas, to include Homeland Defense and Security, Alternative Energy, Weapons of Mass Destruction, Biometrics, and Critical Infrastructure Protection.

Read the Journal

Countermeasures Against the Degradation of Warfighter Capabilities due to Infectious Disease Threats

This State of the Art Report explores the impact of infectious disease on military personnel, providing both an historical and ongoing risk profile of the various infectious diseases that put the warfighter at risk. It includes a look at the historical impact of infectious diseases on past conflicts before going on to detail current and future infectious disease risks, their impact on the warfighter, and challenges in prevention or treatment, and concludes with a quick-look summary of state of the art developments and recommended countermeasures to aid leaders during training and planning. Read the SOAR

Protecting Critical Infrastructure in the Digital Age

Volume 6, Issue 4 of the HDIAC Journal covers four of HDIAC's eight focus areas with articles on Critical infrastructure Protection, Biometrics, Medical, and Alternative Energy.

Read the Journal

Welcome to the HDIAC

Stephen Redifer, Director of the Homeland Defense and Security Information Analysis Center (HDIAC) welcomes you to your community of practice.

The mission of the HDIAC is to provide users with focused expert technical consulting and unbiased scientific and technical information through in-depth analysis and the creation of specialized information products in support of the HDIAC' s eight vital technical focus areas.

Read the Director's Welcome